SEC Form EFFECT filed by Albireo Pharma Inc.

3/9/23 12:15:12 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 8, 2023

Accession Number:

0001193125-23-058273

Submission Type:

POS AM

Date	Price Target	Rating	Analyst
1/9/2023	$53.00 → $42.00	Outperform → Neutral	Wedbush
9/8/2022	$55.00	Buy	Guggenheim
3/28/2022	$75.00	Outperform	Wedbush
11/5/2021	$79.00 → $80.00	Buy	HC Wainwright & Co.
9/16/2021	$82.00 → $84.00	Outperform	Wedbush
7/21/2021	$73.00 → $82.00	Outperform	Wedbush

Recent Analyst Ratings for
$ALBO